Ucrest Bhd
KLSE:UCREST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (13.7), the stock would be worth MYR-0.04 (156% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -24.6 | MYR0.07 |
0%
|
| Industry Average | 13.7 | MYR-0.04 |
-156%
|
| Country Average | 16.5 | MYR-0.04 |
-167%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
U
|
Ucrest Bhd
KLSE:UCREST
|
48.3m MYR | -24.6 | 10.6 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 88.6 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 36.2 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
28.1B USD | 20.3 | 30.9 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.2B AUD | 119.4 | 60.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 23.5 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.2B SEK | 79.2 | 91.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD | 15.1 | 19.3 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4B USD | 8.6 | 35 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
283.9B INR | -201.6 | 42.8 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.1B CNY | 80 | -62.1 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 10.7 |
| Median | 16.5 |
| 70th Percentile | 31.5 |
| Max | 143 415.1 |
Other Multiples
Ucrest Bhd
Glance View
Ucrest Bhd.is an investment holding company, which engages in the design, development, and marketing of information technology products and services. The company is headquartered in Petaling Jaya, Selangor. The company went IPO on 2001-01-01. The firm is a provider of advanced cloud hospital and mobile health services. The firm provides iMedic application, which helps people with chronic conditions and other health conditions who may need to track daily health metrics, such as blood pressure, glucose, and oxygen saturation and more. The iMedic Cloud Hospital is used by renowned doctors and patients in the United States, China, Singapore, Malaysia, Taiwan, Indonesia, Russia and Middle East countries for the diagnosis, management and treatment of chronic diseases, such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation and other diseases. Patients can upload test reports and Computed tomography (CT) scan, X-radiation (X-ray) and ultrasound done at the hospital to i-Medic Cloud Hospital.
